Compare PRFX & BLUWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRFX | BLUWW |
|---|---|---|
| Founded | 2007 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 1.8M |
| IPO Year | 2020 | 2025 |
| Metric | PRFX | BLUWW |
|---|---|---|
| Price | $0.96 | $0.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 69.1K | N/A |
| Earning Date | 11-14-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | N/A |
| 52 Week High | $16.63 | N/A |
| Indicator | PRFX | BLUWW |
|---|---|---|
| Relative Strength Index (RSI) | 45.94 | N/A |
| Support Level | $0.91 | N/A |
| Resistance Level | $0.98 | N/A |
| Average True Range (ATR) | 0.09 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 39.02 | 0.00 |
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.